Tatva Chintan Pharma Chem Limited IPO (Tatva Chintan IPO)
Tatva Chintan Pharma Chem Limited, a Gujarat-based speciality chemical company, will hit the market on Friday, July 16, 2021, to raise Rs 500 crores through an Initial Public Offering (IPO) of its units. The company has set the IPO date as well as the price range at which the shares will be offered for sale. Let’s take a peek at the particulars of the Tatva Chintan IPO.
Tatva Chintan IPO Date & Price Band
| IPO Open: | 16 July 2021 |
| IPO Close: | 20 June 2021 |
| Issue Type: | Book Built Issue IPO |
| Issue Size: | Approx ₹500 Crores |
| Fresh Issue: | Approx ₹225 Crores |
| Offer for Sale: | Approx ₹275 Crores |
| Face Value: | ₹10 Per Equity Share |
| Price Band: | ₹1073 – ₹1083 Per Equity Share |
| Listing on: | BSE, NSE |
Tatva Chintan IPO Market Lot
| Minimum Lot Size: | Minimum 13 Shares |
| Minimum Amount: | ₹14,079 |
| Minimum Lot Size: | Maximum 182 Shares |
| Minimum Amount: | ₹1,97,106 |
Tatva Chintan IPO Allotment & Listing
| Basis of Allotment: | 26 July 2021 |
| Refunds: | 27 July 2021 |
| Credit to Demat Account: | 28 July 2021 |
| Listing Date: | 29 July 2021 |
Financials of Tatva Chintan Pharma Chem Limited IPO
| Particulars | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 |
| Total Assets (in ₹ millions) | 3,148.03 | 2,489.38 | 1,875.08 |
| Total Revenue (in ₹ millions) | 3,062.92 | 2,646.22 | 2,068.01 |
| Profit After Tax (in ₹ millions) | 522.62 | 377.89 | 205.43 |
About Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited, established in 1996, is a producer of structural control agents (SDAs), phase transmission catalyst (PTCs), intermediates for pharmaceutical and agrochemical processing and other chemicals. It is one of India’s biggest producers of zeolite SDAs.
The company serves clients from all industries, including automotive, oil, agrochemical, dyes and pigments, paints and lacquers, pharmaceutical and personal care. Its products are sold not only in India but are also exported worldwide to 25+ countries including the USA, Germany, South Africa, China and the United Kingdom. In the financial year 2020, total exports represented 76% of total operating revenue.
Some of the company’s customers are Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited and Hawks Chemical Company, Firmenish Aromatics Prod Pvt. At present, it has two Ankleshwar and Dahej facilities in Gujarat.
Objective of the Issue:
The company plans to use the funds from the IPO for the following purposes:
- Funding of capital expenditures for the expansion of the manufacturing factory in Dahej.
- Funding of capital expenditure for upgrading R&D facility in Vadodara.
- To fulfil general corporate objectives.